Nausea and vomiting of pregnancy - What's new?

TLDR: An overview of nausea and vomiting of pregnancy is provided to provide an overview of the disorder, possible links between the most important factors associated with the pathogenesis of NVP are presented and the effectiveness and safety of the pharmacologic and non-pharmacologic options available to treat this disorder are discussed.

Abstract: Nausea and vomiting of pregnancy (NVP) is one of the most common disorders of pregnancy The symptoms occur predominantly during the first trimester, although in a subgroup of patients they can continue throughout the entire pregnancy and can affect the woman's quality of life A small percentage of women develop a severe form of NVP called hyperemesis gravidarum (HG) that if left untreated may lead to significant maternal morbidity and adverse birth outcomes Overall, the morbidity in pregnant women with NVP is significant, although it tends to be underestimated The pathogenesis of NVP remains unclear, but there is consensus that the disorder is multifactorial and that various genetic, endocrine and infectious factors may be involved The treatment of NVP can be challenging as the optimal targets for therapy are not known Currently, the therapy used depends on the severity of the disorder and it is focused on improving the symptoms while minimizing risks to mother and fetus Therapies range from dietary changes, pharmacologic treatment or hospitalization with intravenous fluid replacement and nutrition therapy The aims of this review are 1) to provide an overview of NVP, 2) to present possible links between the most important factors associated with the pathogenesis of NVP and 3) to discuss the effectiveness and safety of the pharmacologic and non-pharmacologic options available to treat this disorder